NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition.
about
Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammationCoadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic EffectsCerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?Diabetic Cardiovascular Disease Induced by Oxidative StressNADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTSEvolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target EngagementTargeting NADPH oxidases in vascular pharmacologyNADPH oxidase as a therapeutic target for oxalate induced injury in kidneysBridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitorsContribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.Estrous cycle-dependent neurovascular dysfunction induced by angiotensin II in the mouse neocortex.Raisanberine protected pulmonary arterial rings and cardiac myocytes of rats against hypoxia injury by suppressing NADPH oxidase and calcium influxNADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.Nox5 and the regulation of cellular function.Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.NADPH oxidases: functions and pathologies in the vasculature.NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia.Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy.The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1.Inhibition of protein kinase C β(2) prevents tumor necrosis factor-α-induced apoptosis and oxidative stress in endothelial cells: the role of NADPH oxidase subunits.Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxideNADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathy.NOX2β: A novel splice variant of NOX2 that regulates NADPH oxidase activity in macrophagesIncreasing glucose 6-phosphate dehydrogenase activity restores redox balance in vascular endothelial cells exposed to high glucoseInfluence of aerobic training on the reduced vasoconstriction to angiotensin II in rats exposed to intrauterine growth restriction: possible role of oxidative stress and AT2 receptor of angiotensin IINox1 oxidase suppresses influenza a virus-induced lung inflammation and oxidative stress.NAD(P)H oxidase-derived reactive oxygen species contribute to age-related impairments of endothelium-dependent dilation in rat soleus feed arteries.Role of reactive oxygen species and redox in regulating the function of transient receptor potential channels.Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology.NOX1, 2, 4, 5: counting out oxidative stress.Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease.Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2Investigation of Pathogenesis of H1N1 Influenza Virus and Swine Streptococcus suis Serotype 2 Co-Infection in Pigs by Microarray Analysis.Regulation of Nox enzymes expression in vascular pathophysiology: Focusing on transcription factors and epigenetic mechanisms.Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor.Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targetsNADPH oxidases: an overview from structure to innate immunity-associated pathologies.Effects of angiotensin II on the cerebral circulation: role of oxidative stress.Advanced glycation end products acutely impair ca(2+) signaling in bovine aortic endothelial cells.
P2860
Q21090498-54E86709-7F6C-459E-8E9F-5B376CBBBD03Q26741423-25B71D9F-9328-47F0-B9A1-B00E3653CCB8Q26751153-6BA6680C-114E-49B8-9E2E-76B14059DB76Q26778017-BC4174EB-B653-4F3C-A3DC-B96965AFA0FCQ26821775-D2367FFE-2BD3-493B-98D2-9D279611BF2CQ26861119-B86CB118-CFC7-41BE-B2FB-FB1F639734EBQ26863500-A0C2B755-ECCF-4FB6-AD2D-DD4615416B98Q27014373-025D93C9-81F5-460F-81F2-FE6007E0B2F7Q28394560-96CC7A79-8CB8-4FD2-BD5F-0A1F05E39670Q30623665-983F20DC-9FEB-49A8-9501-C997CE60B6B5Q33464075-0A800C4A-BBED-450A-B517-C4919434D6CCQ33567412-15F09C34-30C9-475D-80DD-F14B066BFE5BQ33632781-1ADC13C6-6897-4102-9716-EB7EBCB146B5Q33649858-901A93A6-2C66-426C-B395-869A99DC2D1AQ33660629-18723A59-3817-4DC3-9F2D-2DA48CA98507Q33739287-8A27E469-6FDB-4D34-8A48-95C2491499DDQ33860500-ECBF452F-7055-450E-A361-2BFAF1E496A4Q33899570-6AE0A922-6932-4E50-AB92-3A1FDF406166Q33907086-E6947915-B497-474E-88BE-653441F5E05FQ34133685-478FB094-0341-4CE0-A9F3-702A35A1C2E3Q34171222-07560319-D03B-405C-AE48-FCAB2FA26F41Q34296737-3A1D1E78-6389-454E-9FFD-A25DC98BF5F0Q34464989-C321ACC6-7E49-4F34-BBD8-37B906588683Q34489884-30B78869-CA92-479D-8057-B47DB93D261EQ34535904-CF518D98-1393-45D6-A9A2-31BA156388A8Q34663971-A5AEDF6A-5ACC-4BF7-A6AE-79A76EE6AD28Q34994570-2D0687D3-AF74-462E-B150-4ABBABAE3AEAQ35151315-25F02511-CBD5-48CB-BEF1-9B222B7D0C18Q35159732-8EBC8B0E-79E2-4F02-B96D-B1640EDDEF3DQ35375986-334986E9-ADA2-435F-A6B0-CACB4C4EC30AQ35450699-C1E33CD7-50C7-46BB-B3F6-28923C80DE79Q35486123-EC5846DD-4CCC-4F5F-83DE-75EA12CA6BBEQ35612870-51EA3895-5B12-440B-9275-BDE108A65DF7Q35849697-305428F8-5724-4A93-8F12-9564AF90FD0EQ35976043-DEE8CAC1-CADB-47E6-B8C0-298E98A1B1F6Q35984159-7A5F4CA8-1A42-4884-80E1-B2D44FAC7973Q35992729-9BDF50D2-C8DD-4B7E-A211-CFA6C20D3FC6Q36302873-A6B9DBCD-C88C-4293-BE29-6CBC533CF7A8Q36516761-D9CAF0F3-B40D-4EA0-89D4-B7B08269D5D2Q36671087-55A59C54-6CA2-4304-9E9A-DD6A3F070D74
P2860
NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NADPH oxidases in the vasculat ...... nd pharmacological inhibition.
@en
NADPH oxidases in the vasculat ...... nd pharmacological inhibition.
@nl
type
label
NADPH oxidases in the vasculat ...... nd pharmacological inhibition.
@en
NADPH oxidases in the vasculat ...... nd pharmacological inhibition.
@nl
prefLabel
NADPH oxidases in the vasculat ...... nd pharmacological inhibition.
@en
NADPH oxidases in the vasculat ...... nd pharmacological inhibition.
@nl
P2093
P1476
NADPH oxidases in the vasculat ...... and pharmacological inhibition
@en
P2093
Christopher G Sobey
Harald H H W Schmidt
Kirstin Wingler
P304
P356
10.1016/J.PHARMTHERA.2008.08.005
P577
2008-08-28T00:00:00Z